Geneva, November 1, 2007. On October 30, 2007, the Board of Directors
of Unilabs SA (SWX: ULB) was informed by the legal representative of
the former shareholders' group consisting of Trident European Fund,
Grand Cayman, Selectium Opportunities Fund, Grand Cayman, Selectium
Europe Fund, Grand Cayman, Susqehanna Ireland Ltd., Dublin, and
GoldenPeaks Capital Partners AG, Zug, of the dissolution of the
shareholders' group, which had been notified to the company on
September 5, 2007. The Board of Directors acknowledges today's
announcement of the shareholders' group to withdraw their request for
an extraordinary general meeting and a separate meeting of the
holders of bearer shares.
The Unilabs Group (SWX: ULB) is the European leader of clinical
testing laboratories. With over 50 laboratories and over 1800
employees operating in 6 countries, Unilabs tests over 3.5 million
samples per year using more than 1500 different tests. Unilabs'
clinical testing services are used by over 60 public and private
hospitals in France, Spain and Switzerland. Unilabs has been listed
on the SWX Swiss Stock Exchange since 1997.
For further information, please contact Christophe Lamps,
(tel. +4122718 37 46 or +4179 476 26 87; mail: email@example.com).
Our press releases are also available on the Internet at our website
--- End of Message ---
C.P. 2559 Genève 1
WKN: 906648; ISIN: CH0012561640;
Index: SPI, SSCI, SBIOM, SLIFE, SPIEX;
Listed: Main Market in SWX Swiss Exchange;